Boston Scientific Corporation vs Hikma Injectables USA Inc.: FDA Enforcement Comparison

Boston Scientific Corporation has been the subject of 285 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Hikma Injectables USA Inc..

Boston Scientific Corporation: 0 warning letters, 285 recalls, 0 approval records, 0 Form 483s.

Hikma Injectables USA Inc.: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Side by side

Boston Scientific Corporation — Warning letters0

Hikma Injectables USA Inc. — Warning letters0

Boston Scientific Corporation — Recalls285

Hikma Injectables USA Inc. — Recalls0

Boston Scientific Corporation — Approval records0

Hikma Injectables USA Inc. — Approval records0

Boston Scientific Corporation — Form 483s0

Hikma Injectables USA Inc. — Form 483s1

Timeline

Boston Scientific Corporation

Most recent FDA action: August 12, 2026

Full history →

Hikma Injectables USA Inc.

Most recent FDA action: August 8, 2025

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Boston Scientific Corporation vs Hikma Injectables USA Inc.: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/boston-scientific-corporation-vs-hikma-injectables-usa-inc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗